DOTAM-TCB: A Universal Small Molecule-Guided Hapten- and T Cell-Bispecific Antibodies for Cancer Immunotherapy

Antibody Therapeutics · Published 2026-07-31 · DOI 10.1093/abt/tbag038

Free full text

Authors (18)

Marlena Surowka, Theresa Kober, Daniela Matscheko, Andreas Ehler, Wilson Macedo, Denis Assisi, John Challier, Andrzej Sobieniecki, Reto Gianotti, Ali Bransi, Johannes Sam, Juan José Bonfiglio, Moreno Wichert, Antonio Ricci, Joerg Benz, Pablo Umaña, Dario Venetz, Christian Klein

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Surowka, M., Kober, T., Matscheko, D., et al. (2026). DOTAM-TCB: A Universal Small Molecule-Guided Hapten- and T Cell-Bispecific Antibodies for Cancer Immunotherapy. Antibody Therapeutics. https://doi.org/10.1093/abt/tbag038

Related articles

• A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells · Molecular Cancer Therapeutics · 2026 · Cites or is cited by this article
• P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy · mAbs · 2025 · Cites or is cited by this article
• The evolving landscape of enzymatic technologies for precision synthesis of antibody–drug conjugates · Antibody Therapeutics · 2026 · Same journal
• Beyond Affinity: AI-Supported Developability Assessment and Multi-Objective Optimization in Antibody Development · Antibody Therapeutics · 2026 · Same journal
• Mass photometry reveals stoichiometry and binding dynamics of bispecific tetravalent anti-VEGF-PD-1 antibody ivonescimab · Antibody Therapeutics · 2026 · Same journal
• Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression · Antibody Therapeutics · 2026 · Same journal
• Delivery devices and container closure systems for co-formulated and co-administered biologics · Antibody Therapeutics · 2026 · Same journal
• Integrative and Emerging Models in Antibody Research: A Comprehensive Review · Antibody Therapeutics · 2025 · Same journal
• Hinge Region Cys-to-Ser Mutation Enables Homogeneous DAR6 Anti-c-Met Biparatopic ADCs with Tolerable O-Glycosylation · Antibody Therapeutics · 2026 · Same journal
• Why antibody isotype matters for immunotherapy · Antibody Therapeutics · 2026 · Same journal